09:35 EDT EXACT Sciences (EXAS) trading resumes
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- EXACT Sciences trading halted, volatility trading pause
- Exact Sciences: Strategic Positioning and Growth Potential Bolstered by Freenome Agreement
- Exact Sciences: Strategic Moves and Strong Performance Justify Buy Rating Despite Market Overreaction
- Exact Sciences price target lowered to $55 from $65 at Barclays
- Exact Sciences Corp. Reports Strong Q2 2025 Results